Events Partner Content 14th Annual Pre-Filled Syringes and Drug Devices 2022 The Future of Drug Delivery and Combination Products
Partner Content Partner Content Regulatory Issues for PF Syringes & Injectable Drug Devi... Pre-Filled Syringes & Injectable Drug Devices Europe
Partner Content Partner Content Full Agenda Released for Pre-Filled Syringes & Injectabl... The Future of Drug Delivery & Combination products
Events Partner Content Pre-Filled Syringes & Injectable Drug Devices Europe SMi is proud to present their 11th annual European
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
